SE402772B - Forfarande for framstellning av nya isotiocyanobensazoler - Google Patents

Forfarande for framstellning av nya isotiocyanobensazoler

Info

Publication number
SE402772B
SE402772B SE7214765A SE1476572A SE402772B SE 402772 B SE402772 B SE 402772B SE 7214765 A SE7214765 A SE 7214765A SE 1476572 A SE1476572 A SE 1476572A SE 402772 B SE402772 B SE 402772B
Authority
SE
Sweden
Prior art keywords
isotiocyanobensazoles
procedure
making new
making
new
Prior art date
Application number
SE7214765A
Other languages
English (en)
Swedish (sv)
Inventor
J-J Gallay
R Bosshard
P Brenneisen
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE402772B publication Critical patent/SE402772B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57Aryl or substituted aryl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE7214765A 1971-12-07 1972-11-14 Forfarande for framstellning av nya isotiocyanobensazoler SE402772B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1787571A CH566321A5 (ru) 1971-12-07 1971-12-07

Publications (1)

Publication Number Publication Date
SE402772B true SE402772B (sv) 1978-07-17

Family

ID=4428743

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7214765A SE402772B (sv) 1971-12-07 1972-11-14 Forfarande for framstellning av nya isotiocyanobensazoler

Country Status (27)

Country Link
US (1) US3849431A (ru)
JP (1) JPS5754511B2 (ru)
AR (1) AR220663A1 (ru)
AT (2) AT322550B (ru)
BE (1) BE792402A (ru)
BG (1) BG21027A3 (ru)
BR (1) BR7208610D0 (ru)
CA (1) CA1014566A (ru)
CH (1) CH566321A5 (ru)
CS (2) CS177148B2 (ru)
DD (1) DD105230A5 (ru)
DE (1) DE2259220C2 (ru)
ES (1) ES409335A1 (ru)
FI (1) FI56531C (ru)
GB (1) GB1413519A (ru)
HU (1) HU167426B (ru)
IE (1) IE37194B1 (ru)
IL (1) IL40935A (ru)
IT (1) IT1048106B (ru)
NL (1) NL7216645A (ru)
NO (1) NO137234C (ru)
PL (2) PL85278B1 (ru)
RO (1) RO60572A (ru)
SE (1) SE402772B (ru)
SU (2) SU589915A3 (ru)
YU (1) YU36711B (ru)
ZA (1) ZA728643B (ru)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933841A (en) * 1971-05-24 1976-01-20 Ciba-Geigy Corporation 2-Phenoxy, -phenylthio-, and -phenyl-amino-benzoxazoles having an isothiocyano substituent
US3894037A (en) * 1971-05-24 1975-07-08 Ciba Geigy Corp Certain isothiocyanobenzimidazoles
US3969351A (en) * 1974-05-17 1976-07-13 E. R. Squibb & Sons, Inc. Morpholine containing isothiocyanobenzoxazoles
LU75684A1 (ru) * 1976-08-27 1978-04-13
CH634306A5 (de) * 1977-04-12 1983-01-31 Ciba Geigy Ag Benzimidazolderivate, verfahren zu ihrer herstellung und anthelmintische mittel enthaltend diese verbindungen als wirkstoffe.
EP0007616B1 (de) * 1978-07-27 1982-05-12 Ciba-Geigy Ag Isothiocyanobenzthiazolderivat, Verfahren zu seiner Herstellung und seine Anwendung in anthelmintischen Mitteln
US4287349A (en) * 1979-04-23 1981-09-01 Standard Oil Company (Indiana) Beta-alkyl (or aryl) beta-hydroxyethyl heterocyclic sulfoxides
FR2459239A1 (fr) * 1979-06-20 1981-01-09 Logeais Labor Jacques Nouveaux derives amines du benzothiazole, leur procede de preparation et leur application en therapeutique
DE2946524A1 (de) * 1979-11-17 1981-06-11 Bayer Ag, 5090 Leverkusen Azolyloxy-carbonsaeure-n-oxy-amide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
US4267348A (en) * 1979-12-04 1981-05-12 The United States Of America As Represented By The Secretary Of The Air Force Fluorine-containing benzimidazoles
US4258188A (en) * 1980-02-04 1981-03-24 American Home Products Corporation 2-(1-Piperazinyl)-cycloheptimidazole derivatives
US4375470A (en) * 1980-02-04 1983-03-01 American Home Products Corporation 2(1-Piperazinyl)-cycloheptimidazole antihypertensive composition and methods
US4321363A (en) * 1980-02-21 1982-03-23 Nippon Soda Company Limited Adsorbent for urokinase containing agarose
MA19290A1 (fr) * 1980-05-22 1982-04-01 Ciba Geigy Ag Derives du benzole,leur preparaton et leur utilisations therapeutiques .
DE3027483A1 (de) * 1980-07-19 1982-02-25 Hoechst Ag, 6000 Frankfurt Verfahren zur herstellung heterocyclisch substituierter 4-oxiphenoxialkancarbonsaeurederivate
DE3039929A1 (de) * 1980-10-23 1982-06-03 Bayer Ag, 5090 Leverkusen Isocyanato-oxazolinone, ein verfahren zur herstellung von oxazolin-2-on-ringe aufweisenden kunststoffvorlaeufern und deren verwendung zur herstellung von hochmolekularen kunststoffen
FR2521141A1 (fr) * 1982-02-09 1983-08-12 Rhone Poulenc Agrochimie Nouveaux derives du cyano-2 benzimidazole, leur preparation et leur utilisation comme fongicides
DE3311285A1 (de) * 1983-03-28 1984-10-11 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung heterocyclischer phenylether
GB8423697D0 (en) * 1984-09-19 1984-10-24 Ciba Geigy Ag Benzazole derivatives
US4873346A (en) * 1985-09-20 1989-10-10 The Upjohn Company Substituted benzothiazoles, benzimidazoles, and benzoxazoles
EP0507464A1 (en) * 1991-03-28 1992-10-07 Zeneca Limited Benzoxazole derivatives
GB9219634D0 (en) * 1992-09-16 1992-10-28 Ici Plc Heterocyclic compounds
FR2708608B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant.
EE200000289A (et) 1997-10-27 2001-06-15 Agouron Pharmaceuticals, Inc. Asendatud 4-amino-tiasool-2-üüli ühendid kui tsükliinisõltuvusega kinaaside inhibiitorid
WO2005074603A2 (en) * 2004-02-03 2005-08-18 Abbott Laboratories Aminobenzoxazoles as therapeutic agents
TW201302775A (zh) * 2011-07-12 2013-01-16 Academia Sinica 可移除式糖類-bim 標幟及其在苯并咪唑之1h-位置上的接合功能

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH542853A (de) * 1967-07-26 1973-10-15 Agripat Sa Verfahren zur Herstellung neuer Isothiocyano-benzazol-Derivate
AT286292B (de) * 1969-01-10 1970-12-10 Agripat Sa Verfahren zur Herstellung von neuen Isothiocyano-benzimidazol- und -benzoxazolderivaten und ihren Salzen

Also Published As

Publication number Publication date
FI56531B (fi) 1979-10-31
CS177148B2 (ru) 1977-07-29
SU541433A3 (ru) 1976-12-30
AT324761B (de) 1975-09-25
DE2259220A1 (de) 1973-06-14
IT1048106B (it) 1980-11-20
AT322550B (de) 1975-05-26
CS177109B2 (ru) 1977-07-29
GB1413519A (en) 1975-11-12
JPS5754511B2 (ru) 1982-11-18
US3849431A (en) 1974-11-19
DE2259220C2 (de) 1984-05-17
DD105230A5 (ru) 1974-04-12
YU298072A (en) 1982-06-18
NO137234B (no) 1977-10-17
NL7216645A (ru) 1973-06-12
NO137234C (no) 1978-01-25
PL85278B1 (ru) 1976-04-30
AR220663A1 (es) 1980-11-28
IL40935A (en) 1976-09-30
IE37194L (en) 1973-06-07
IE37194B1 (en) 1977-05-25
SU589915A3 (ru) 1978-01-25
BG21027A3 (ru) 1976-01-20
CA1014566A (en) 1977-07-26
ES409335A1 (es) 1976-04-16
FI56531C (fi) 1980-02-11
CH566321A5 (ru) 1975-09-15
RO60572A (ru) 1976-12-15
BR7208610D0 (pt) 1973-09-20
JPS4864067A (ru) 1973-09-05
BE792402A (fr) 1973-06-07
HU167426B (ru) 1975-10-28
AU4949472A (en) 1974-05-30
PL86697B1 (ru) 1976-06-30
IL40935A0 (en) 1973-01-30
ZA728643B (en) 1973-08-29
YU36711B (en) 1984-08-31

Similar Documents

Publication Publication Date Title
SE7509456L (sv) Forfarande for framstellning av nya pleuromutiliner
SE402772B (sv) Forfarande for framstellning av nya isotiocyanobensazoler
FI56839B (fi) Foerfarande foer framstaellning av nya antibakteriella penicillinderivat
SE386445B (sv) Forfaranden for framstellning av nya bensotiadiazoler
SE399268B (sv) Forfarande for framstellning av nya purinnukleosidderivat
FI55188C (fi) Foerfarande foer framstaellning av nya osymmetriska 1 4-dihydropyridindikarboxylsyraestrar
SE401186B (sv) Forfarande for framstellning av nya penicilliner
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE395893B (sv) Forfarande for framstellning av vincamin
SE395885B (sv) Forfarande for framstellning av nya kortikotropinpeptider
SE390538B (sv) Forfarande for framstellning av nya acylaminocefalosporansyror
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE383631B (sv) Forfarande for framstellning av nya 1-fenoxi-2-hydroxid-3-hydroxialkylaminopropaner
SE384027B (sv) Forfarande for framstellning av nya alfa-alkylsulfobensylpenicilliner
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE384210B (sv) Forfarande for framstellning av nya nitrosokarbamidderivat
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE387949B (sv) Forfarande for framstellning av nya piperazinyl-tiazolderivat
SE381054B (sv) Forfarande for framstellning av nya tiazolokinolinderivat
NO136537C (no) Fremgangsm}te for fremstilling av iminer
SE410969B (sv) Forfarande for framstellning av nya alkylfenylbensopyranopyridiner
SE404361B (sv) Forfarande for framstellning av nya 1-fenyl-3hydroxi-3-metyl-triazener
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE394112B (sv) Forfarande for framstellning av nya estrar av bensopyraner.